###begin article-title 0
Positive Regulatory Control Loop between Gut Leptin and Intestinal GLUT2/GLUT5 Transporters Links to Hepatic Metabolic Functions in Rodents
###end article-title 0
###begin p 1
Conceived and designed the experiments: YS RD AB. Performed the experiments: YS CN PL AAO MA RD AB. Analyzed the data: YS PL RD AB. Contributed reagents/materials/analysis tools: BV. Wrote the paper: YS RD AB.
###end p 1
###begin title 2
Background and Aims
###end title 2
###begin p 3
The small intestine is the major site of absorption of dietary sugars. The rate at which they enter and exit the intestine has a major effect on blood glucose homeostasis. In this study, we determine the effects of luminal leptin on activity/expression of GLUT2 and GLUT5 transporters in response to sugars intake and analyse their physiological consequences.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 36 37 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 37 40 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 57 65 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 70 77 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 11 <span type="species:ncbi:10116">Wistar rats</span>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Wistar rats, wild type and AMPKalpha2-/- mice were used. In vitro and in vivo isolated jejunal loops were used to quantify transport of fructose and galactose in the absence and the presence of leptin. The effects of fructose and galactose on gastric leptin release were determined. The effects of leptin given orally without or with fructose were determined on the expression of GLUT2/5, on some gluconeogenesis and lipogenic enzymes in the intestine and the liver.
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 7 15 7 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 215 222 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 558 560 551 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i)</italic>
###xml 635 638 628 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii)</italic>
###xml 770 774 763 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iii)</italic>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
First, in vitro luminal leptin activating its receptors coupled to PKCbetaII and AMPKalpha, increased insertion of GLUT2/5 into the brush-border membrane leading to enhanced galactose and fructose transport. Second in vivo, oral fructose but not galactose induced in mice a rapid and potent release of gastric leptin in gastric juice without significant changes in plasma leptin levels. Moreover, leptin given orally at a dose reproducing comparable levels to those induced by fructose, stimulated GLUT5-fructose transport, and potentiated fructose-induced: i) increase in blood glucose and mRNA levels of key gluconeogenesis enzymes; ii) increase in blood triglycerides and reduction of mRNA levels of intestinal and hepatic Fasting-induced adipocyte factor (Fiaf) and iii) increase in SREBP-1c, ACC-1, FAS mRNA levels and dephosphorylation/activation of ACC-1 in liver.
###end p 7
###begin title 8
Conclusion/Significance
###end title 8
###begin p 9
These data identify for the first time a positive regulatory control loop between gut leptin and fructose in which fructose triggers release of gastric leptin which, in turn, up-regulates GLUT5 and concurrently modulates metabolic functions in the liver. This loop appears to be a new mechanism (possibly pathogenic) by which fructose consumption rapidly becomes highly lipogenic and deleterious.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 441 444 441 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kellett1">[1]</xref>
###xml 446 449 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kellett2">[2]</xref>
###xml 848 851 848 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kellett1">[1]</xref>
###xml 978 981 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Barone1">[3]</xref>
###xml 1182 1185 1182 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ferraris1">[4]</xref>
###xml 1240 1243 1237 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ishikawa1">[5]</xref>
###xml 1310 1313 1307 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Au1">[6]</xref>
###xml 1315 1318 1312 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Cheeseman1">[7]</xref>
###xml 1393 1396 1390 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Hirsh1">[8]</xref>
###xml 1412 1415 1409 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ducroc1">[9]</xref>
The small intestine is involved in delivering sugars to the systemic circulation through absorption of the products arising from carbohydrate digestion. The rate at which dietary sugars enter and exit the intestinal epithelium has a major effect on blood glucose concentration and homeostasis. Briefly, dietary carbohydrates are taken into the enterocytes by specific transporters and exit the cell through the basolateral GLUT2 transporter [1], [2]. In pre-prandial state, glucose transport is an active process which involves the co-transport of sugar with sodium ions through the sodium-glucose transporter-1, SGLT-1. In prandial state, when higher concentrations of glucose or galactose are found in the intestinal lumen, apical GLUT2 becomes active providing the small intestine with an absorptive capacity to match dietary intake during meal [1]. This apical GLUT2 transporter also participates to fructose transport in addition to the main and specific GLUT5 transporter [3]. All these membrane transporters are highly regulated during food intake by changing their activity levels, their location within the enterocyte and by regulating the expression of the encoding genes [4]. They are also controlled by beta-adrenergic agonists [5], gastrointestinal hormones such as glucagon-like peptide-2, GLP-2 [6], [7], glucose-dependent insulinotropic polypeptide, GIP, cholecystokinin (CCK) [8], and by leptin [9].
###end p 11
###begin p 12
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Bado1">[10]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Bado1">[10]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Cammisotto1">[11]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Guilmeau1">[12]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Plaisancie1">[13]</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Buyse1">[14]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Cammisotto2">[15]</xref>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Buyse1">[14]</xref>
###xml 1012 1016 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Buyse2">[16]</xref>
###xml 1095 1098 1095 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ducroc1">[9]</xref>
###xml 1146 1149 1146 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kellett1">[1]</xref>
Initially characterized as an adipocyte specific protein controlling body weight and adiposity, leptin is now considered as an hormone with pleiotropic biological effects. This status of leptin is consistent with the production of leptin by various tissues and organs including the stomach. The stomach-derived leptin is rapidly and mainly secreted into the gastric juice after a meal [10] where it is not fully degraded even at pH 2 [10], [11]. The released leptin enters the intestine and is detected in intestinal juices from duodenum to the colon as both free leptin and leptin bound to its soluble receptor Ob-Re [12], [13] as previously reported for plasma leptin. The demonstration that leptin receptors are present all along the small and large intestine [14], [15], are in line with leptin, acting at the luminal side to enhance intestinal absorption of oligopeptides mediated by the proton-dependent PepT1 transporter [14], to increase monocarboxylate transporter MCT-1 butyrate uptake in Caco-2 cells [16], and to inhibit the active component of glucose absorption mediated by SGLT-1 [9]. However, whether the apical GLUT2 transporter [1] which is active during a meal and the fructose GLUT5 transporter can be direct targets for luminal leptin, is unknown.
###end p 12
###begin p 13
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Elliott1">[17]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Bray1">[18]</xref>
###xml 481 488 481 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 310 315 <span type="species:ncbi:9606">human</span>
The aim of the present study was to investigate the effects of luminal leptin (mimicking gastric leptin) on the transport activities and expression of GLUT2 and GLUT5 transporters in the small intestine and to analyse the intracellular mechanisms involved. Since fructose represents an important ingredient in human diets due to the extensive use of high-fructose sweeteners [17], [18], and it has been described as a contributing factor in the metabolic syndrome, we analysed the in vivo effects of luminal leptin regulation of fructose absorption on some key indices of lipid and carbohydrates metabolism. Then, we questioned the physiological relevance of the data by determining whether fructose ingestion modulated gastric leptin and whether this leptin is actually entering into the intestinal lumen.
###end p 13
###begin p 14
###xml 498 502 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vivo</italic>
###xml 598 600 584 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i)</italic>
###xml 715 718 701 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii)</italic>
###xml 937 941 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iii)</italic>
In this study, we demonstrated that luminal leptin, acting from lumen of the intestinal epithelium, increases GLUT2 and GLUT5 transport activities through leptin-receptor coupled to activation of protein kinase C subunit betaII (PKCbetaII) and 5'AMP-activated protein kinase subunit alpha (AMPKalpha). We also demonstrated, for the first time, that oral fructose rapidly induces the release of leptin in the gastrointestinal lumen without significantly affecting plasma leptin levels. Moreover, in vivo oral leptin-induced stimulation of GLUT5-mediated fructose transport has several consequences: i) a significant rise in blood glucose levels associated with changes in mRNA levels of key gluconeogenesis enzymes; ii) an increase in circulating levels of triglycerides associated with a reduced transcription of intestinal and hepatic fasting-induced adipocyte factor (Fiaf), encoding a secreted lipoprotein lipase (LPL) inhibitor, and iii) enhanced transcription of sterol regulatory element-binding protein-1c (SREBP-1c), acetyl-coA carboxylase isoform 1 (ACC-1) and fatty acid synthase (FAS) in the liver.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Luminal Leptin Increases GLUT5-Mediated Fructose Transport
###end title 16
###begin p 17
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 94 97 94 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">app</sub>
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 117 123 117 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1</xref>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 323 329 323 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1</xref>
###xml 491 493 491 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
Addition of leptin into jejunum loop in vitro, induced a concentration-dependent increase in Papp of [14C]-fructose (fig. 1, A) with a maximal increase occurring with 1 nM leptin (P<0.01 vs. CTRL). This transepithelial transport of fructose was rapid and time-dependently increased with 1 nM leptin added into the jejunum (fig. 1, B). Addition of CCK-8 in the serosal side did not significantly affect fructose transport. Under these conditions, luminal addition of leptin had no effect on [14C]-mannitol transport (data not shown), indicating that the increase in fructose transport was unlikely to have been caused by a change in passive tissue permeability.
###end p 17
###begin title 18
Luminal leptin increases GLUT2 and GLUT5 transport activities.
###end title 18
###begin p 19
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(M)</italic>
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(S)</italic>
###xml 100 104 100 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1, A</bold>
###xml 130 134 130 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1, E</bold>
###xml 197 205 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 358 363 356 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B, F,</bold>
###xml 415 416 413 414 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 432 433 430 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 479 487 477 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 552 557 550 555 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C, G,</bold>
###xml 714 715 708 709 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 732 733 726 727 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 779 787 773 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 897 902 889 894 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D, H,</bold>
###xml 1261 1264 1250 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 179 182 <span type="species:ncbi:10116">rat</span>
###xml 352 356 <span type="species:ncbi:10116">rats</span>
###xml 461 464 <span type="species:ncbi:10116">rat</span>
###xml 761 764 <span type="species:ncbi:10116">rat</span>
###xml 891 895 <span type="species:ncbi:10116">rats</span>
###xml 1001 1004 <span type="species:ncbi:10116">rat</span>
Dose-response effect for luminal leptin stimulation of mucosal (M) to serosal (S) fructose [30 mM, (1, A)] or galactose [100 mM, (1, E)] transepithelial transport in the isolated rat jejunal loops in vitro. CCK8 (8 pM) was added to the serosal side. Data are expressed as apparent permeability (Papp) and each column represents the mean+/-SEM of n = 6 rats. B, F, Kinetic of luminal leptin stimulation of fructose (B) or galactose (F) transport in the isolated rat jejunal loops in vitro. CCK8 (8 pM) was added in the incubation medium (serosal side). C, G, Effects of phloretin (PHLO, 1 mM) and cytochalasin B (CytoB, 20 microM), two GLUT2 inhibitors, on basal and leptin-induced mucosal to basolateral fructose (C) and galactose (G) transport in the isolated rat jejunal loops in vitro. Data are expressed as apparent permeability (Papp) and each column represents the mean+/-SEM of n = 8 rats. D, H, Representative immunoblots of GLUT5, GLUT2 and beta-actin proteins in brush-border membranes from rat jejunum treated with or without luminal leptin in association with or without fructose (30 mM) and galactose (100 mM) into the isolated jejunal loop. Results of densitometric analysis are expressed as relative protein levels. *P<0.05; **P<0.01,*** P<0.001 vs. NaCl.
###end p 19
###begin p 20
###xml 133 139 133 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1</xref>
###xml 228 231 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Barone1">[3]</xref>
###xml 336 342 336 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1</xref>
On the other hand, addition of phloretin significantly reduced by 20% (P<0.05) both basal- and leptin-stimulated fructose transport (fig. 1, C) consistent with the involvement of a small component of GLUT2 in fructose transport [3]. The addition of cytochalasin B also reduced basal and suppressed leptin-stimulated fructose transport (fig. 1, C).
###end p 20
###begin p 21
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kellett1">[1]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kellett3">[19]</xref>
###xml 262 268 262 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1</xref>
###xml 367 370 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
The intestinal absorption of sugars is often associated with substrate-induced translocation of transporters to apical membranes [1], [19]. We observed that leptin-stimulated fructose transport was associated with an increased level of GLUT5 protein in the BBM (fig. 1, D). Thus, luminal fructose induced a 2.2-fold increase in the levels of GLUT5 in the BBM (P<0.01 vs. CTRL) and when combined with leptin, this level was 3.4 times higher than in controls.
###end p 21
###begin title 22
Luminal Leptin Increases GLUT2-Mediated Galactose Transport
###end title 22
###begin p 23
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 141 147 141 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1</xref>
###xml 209 212 209 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">app</sub>
###xml 252 254 252 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 624 631 624 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1F</xref>
###xml 634 636 634 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1025 1031 1025 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1</xref>
###xml 1103 1110 1103 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g001">fig. 1H</xref>
###xml 51 54 <span type="species:ncbi:10116">rat</span>
As for fructose transport, addition of leptin into rat jejunum loop in vitro induced a concentration-dependent increase in galactose uptake (fig. 1, E). The maximal effect of leptin on apparent permeability (Papp) of galactose (2-fold increase; P<0.01 vs. control) occurred with 5 nM luminal leptin compared to 1 nM for fructose transport. These apparent different sensitivities of GLUT2 and GLUT5 could be related to the high concentration of galactose used in the study taking into account the differences in Km of the two transporters and, we used the dose of 5 nM for the time course studies for galactose transport. In fig. 1F, [14C]-galactose transport across the jejunum (mucosal to serosal) significantly increased over time; this effect was enhanced by luminal addition of 5 nM leptin. Addition of CCK-8 at the serosal side (incubation bath) had no significant effect. Moreover, the leptin stimulation of galactose transport was markedly reduced by phloretin and cytochalasin B, two inhibitors of GLUT2 transporter (fig. 1, G) suggesting that GLUT2 transporter is a direct target of leptin. In fig. 1H, we found that luminal leptin significantly increased the levels of GLUT2 at the BBM: with 1 nM leptin, GLUT2 levels increased by 2-fold (P<0.01 vs. control). Galactose (100 mM) induced a 3-fold increase in GLUT2 levels in the BBM and this effect was not further increased by addition of leptin into the jejunum.
###end p 23
###begin title 24
Leptin's Action Is Leptin-Receptor Specific
###end title 24
###begin p 25
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Salomon1">[20]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Gertler1">[21]</xref>
###xml 331 337 331 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g002">fig. 2</xref>
###xml 415 423 415 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 446 448 446 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 462 468 462 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g002">fig. 2</xref>
###xml 477 479 477 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 492 498 492 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g002">fig. 2</xref>
###xml 63 69 <span type="species:ncbi:10090">murine</span>
To address receptor specificity of leptin'effects, we used the murine L39A/D40A/F41A leptin mutein, a recent developed recombinant leptin analog in which alanine was substituted for amino acids expressed in positions 39, 40, and 41 of wild-type leptin. This leptin mutein behaves as an antagonist of leptin receptor [20], [21]. In fig. 2, we found that addition of L39A/D40A/F41A mutein into isolated jejunal loops in vitro did not affect basal [14C]-galactose (fig. 2, A) or [14C]-fructose (fig. 2, B) transport but dose-dependently prevented leptin stimulation of both galactose and fructose transport.
###end p 25
###begin title 26
Actions of leptin require active jejunal leptin receptors.
###end title 26
###begin p 27
###xml 134 135 134 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 153 154 153 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 462 463 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 177 180 <span type="species:ncbi:10116">rat</span>
###xml 319 323 <span type="species:ncbi:10116">rats</span>
Effects of a leptin receptor antagonist, L39A/D40A/F41A mutein on basal and luminal leptin-stimulated mucosal to serosal D-galactose (A) and D-fructose (B) transport across the rat jejunum. Shown are apparent permeability (Papp) of galactose and fructose across the jejunum. Each column represents mean+/-SEM for n = 6 rats. Statistical analysis was performed using One-way ANOVA followed by a Tukey Kramer multiple comparisons *P<0.05, ***P<0.001 vs. control. (C) Leptin receptors in the jejunum mucosa are functional. Shown are representative immunoblots (4 separate experiments) of phosphorylated ERK-1/2 and total ERK proteins in extracts from isolated jejunum treated with luminal leptin or fructose or both in association. The introduction of leptin into jejunum increased phosphorylation of ERK-1/2. Luminal fructose also increased phosphorylation of ERK-1/2, an effect that was further enhanced by leptin. AICAR, the pharmacological activator of AMPK increased the phosphorylation ERK-1/2.
###end p 27
###begin p 28
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 151 158 151 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007935.s001">Text S1</xref>
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007935.s002">fig. S1</xref>
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007935.s002">fig. S1</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fa/fa</italic>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Guilmeau1">[12]</xref>
###xml 473 476 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ducroc1">[9]</xref>
###xml 16 19 <span type="species:ncbi:10116">rat</span>
###xml 462 466 <span type="species:ncbi:10116">rats</span>
In addition, in rat, the in vivo leptin stimulation of GLUT2-mediated galactose transport was associated with a rise of galactose levels in the blood (Text S1, fig. S1). Moreover, addition of L39A/D40A/F41A, a leptin antagonist, completely prevented leptin-induced increase in blood galactose (fig. S1). This indicates that the effects of luminal leptin are dependent upon leptin receptor, consistent with our previous data using leptin-receptor deficient fa/fa rats [12], [9].
###end p 28
###begin p 29
###xml 151 157 151 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g002">fig. 2</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Cha1">[22]</xref>
These leptin receptors were further demonstrated to be functional since they are responsive to luminal leptin alone or combined with luminal fructose (fig. 2, C). Indeed, activation of leptin receptor by introduction of leptin into the lumen of the jejunum loop, increased phosphorylation of ERK-1/2 consistent with the well-known coupling of activated leptin-receptor to MAPkinase signaling pathways. It is noteworthy that luminal fructose increased phosphorylation of ERK-1/2, an effect that was further enhanced by leptin. Similarly, AICAR, a pharmacological activator of AMPK, induced a strong phosphorylation of ERK-1/2 proteins in jejunal mucosa. These data can be compared with the capacity of central fructose to sense via activation of hypothalamic AMPK/malonyl-CoA signaling pathways [22].
###end p 29
###begin title 30
The Leptin Stimulation of Fructose Transport Is Associated with Increase Phosphorylated PKCbetaII in the BBM
###end title 30
###begin p 31
###xml 158 162 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Helliwell1">[23]</xref>
###xml 329 335 323 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g003">fig. 3</xref>
Previous studies have shown that the increase in recruitment of sugar transporters to the BBM requires activation of the betaII-isoenzyme of protein kinase C [23]. In this study, luminal fructose increased phosphorylation of PKCbetaII in the BBM, an effect which was further enhanced by addition of 1 nM leptin into the jejunum (fig. 3, A). These data might indicate that leptin enhances fructose transport, by increasing phosphorylation/activation of PKCbetaII and by recruiting more GLUT5 proteins into the BBM.
###end p 31
###begin title 32
Luminal leptin phosphorylates PKCbetaII and AMPKalpha in the jejunum.
###end title 32
###begin p 33
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,</bold>
###xml 333 335 324 326 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,</bold>
###xml 766 769 753 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 776 781 763 768 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C, D,</bold>
###xml 838 839 821 822 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 911 913 890 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E,</bold>
###xml 1015 1016 990 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 108 111 <span type="species:ncbi:10116">rat</span>
###xml 446 449 <span type="species:ncbi:10116">rat</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
###xml 1165 1169 <span type="species:ncbi:10090">mice</span>
A, A representative immunoblot (5 different preparations of BBM) of phosphorylated and total PKCbetaII from rat jejunum loops treated with or without luminal leptin in association with or without 30 mM fructose. The data of densitometric analysis of the blots are expressed as a ratio of phosphorylated PKCbetaII to total PKCbetaII. B, a representative immunoblot (4 separate experiments) of phosphorylated and total AMPK from mucosa extracts of rat jejunum loops incubated with or without (CTRL) 1 nM leptin in association without or with 30 mM fructose. 5-aminoimidazole-4-carboxamide riboside (2.5 mM AICAR) was used as control. Data of densitometric analysis are expressed as a ratio of phosphorylated AMPKalpha to total AMPK. *P<0.05, ** P<0.01 and *** P<0.001 vs. CTRL. C, D, histological analysis of jejunum sections from AMPKalpha2-/- and WT mice stained with hematoxylin-eosin (scale bar = 20 microm). E, representative immunoblots of GLUT2 and GLUT5 proteins in extracts from jejunum mucosa from AMPKalpha2-/- and WT mice. Data of densitometric analysis of the blots are expressed as relative protein levels. Each column represent the mean+/-SEM of n = 5 mice in each group. *** P<0.001 vs WT.
###end p 33
###begin title 34
Leptin-Stimulated Fructose Transport Results in a Concurrent Increase of AMPK Phosphorylation
###end title 34
###begin p 35
###xml 73 82 73 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">review in</italic>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Hardie1">[24]</xref>
###xml 312 318 308 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g003">fig. 3</xref>
###xml 453 459 445 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g003">fig. 3</xref>
AMPK has been previously implicated in the regulation of glucose uptake (review in[24]). We examined whether AMPK can mediate the action of leptin in the intestine. We found that luminal leptin alone or in association with fructose significantly increased phosphorylation of the catalytic alpha subunit of AMPK (fig. 3, B). Indeed, fructose or leptin (1 nM) added into the lumen increases phosphorylation of AMPKalpha by 2-fold as compared to controls (fig. 3, B). Interestingly, treatment with a combination of fructose and leptin gave levels of phosphorylated AMPKalpha 3-fold higher than those observed in controls (P<0.05). This increased phosphorylation was similar to that induced by AICAR, a pharmacological activator of AMPK. These data argue for the involvement of the alpha subunit of AMPK in mediating the effects of leptin.
###end p 35
###begin p 36
###xml 22 23 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 43 44 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 88 89 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 252 253 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 264 270 248 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g003">fig. 3</xref>
###xml 347 348 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 365 339 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g003">fig. 3</xref>
###xml 542 543 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 581 588 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007935.s001">Text S1</xref>
###xml 590 597 566 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007935.s003">fig. S2</xref>
###xml 785 788 761 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isc</italic>
###xml 842 843 814 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1039 1040 1007 1008 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
We next used AMPKalpha2 knockout (AMPKalpha2-/-) mice to further study the role of alpha2 subunit of AMPK in the effects of leptin. Histological analysis showed that there was no difference in the architecture of jejunum mucosa between WT and AMPKalpha2 -/- mice (fig. 3, C, D). However, Western blot analysis of extracts from jejunum of AMPKalpha2 -/- mice (fig. 3, E) showed that levels of GLUT2 and GLUT5 proteins were three times lower than in the jejunum of WT mice (P<0.001). In parallel, SGLT-1 transporters were increased in AMPKalpha2-/- by 2-fold as compared to WT mice (Text S1, fig. S2). The transport activity of SGLT-1 was determined in Ussing chamber. The addition of 10 mM glucose into the mucosal bath led to a rapid and significant rise in the short circuit current (Isc) which was 2.3 times higher in jejunum from AMPKalpha2-/- mice than in jejunum from WT mice (P<0.01). These data indicate that leptin controls the activity/expression of sugar transporters in the small intestine through mechanisms requiring the alpha2 subunit of AMPK.
###end p 36
###begin title 37
Oral Leptin Increases GLUT2 and GLUT5 mRNA Levels in the Jejunum
###end title 37
###begin p 38
###xml 62 66 <span type="species:ncbi:10090">mice</span>
We have determined whether administration of 3 ng/g leptin to mice by gavage either alone or with fructose, could replenish the cytosolic pool of transporters by increasing the levels of their mRNA levels. This dose of leptin was chosen from our pilot experiments showing that the peptide given by gavage generates levels of leptin similar to those detected in the stomach after meal. Moreover, 15 min after gavage, 70% of the peptide was detected in the small intestine representing a concentration sufficient to activate leptin receptors.
###end p 38
###begin p 39
###xml 12 19 12 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g004">fig. 4A</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Cui1">[25]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Gouyon1">[26]</xref>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
As shown in fig. 4A, mice receiving leptin by gavage, had 1.6-fold and 2 -fold higher levels of GLUT2 and GLUT5 mRNAs in the jejunum respectively, than control mice receiving saline. Oral load of fructose increased by 3-fold (P<0.01 vs CTRL) and 5-fold (P<0.01 vs CTRL) GLUT2 and GLUT5 mRNA levels, respectively, consistent with previous reports [25], [26]. Leptin given together with oral fructose significantly enhanced this effect, increasing GLUT2 mRNA levels by a factor of 4 (vs. 3-fold for fructose) and those of GLUT5 by a factor of 7 (vs. 5-fold).
###end p 39
###begin title 40
Acute and chronic leptin administration increase basal and fructose-stimulated GLUT2 and GLUT5 mRNA.
###end title 40
###begin p 41
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,</bold>
###xml 409 411 407 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,</bold>
###xml 781 790 777 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B insert,</bold>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">Mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
A, for acute studies, 16-hour deprived fasted mice receiving oral administration of saline (CTRL), 3 ng/g murine leptin, fructose (2 g/kg) or fructose in combination with leptin. They were sacrified 4 hours later, and total RNA was extracted from the jejunum mucosa for qRT-PCR analysis in duplicate using specific oligonucleotides for GLUT2 and GLUT5 genes. Results are means+/-SEM for 8 mice in each group. B, for chronic studies, mice fed a standard diet (SD) or a high-calorie diet (HFD), received saline (CTRL) or 3 ng/g leptin, administered daily by gavage for 7 days. Mice were killed on day 8 and total RNA was extracted from jejunum mucosa for qRT-PCR analysis. Results are means+/-SEM for 8 mice in each study and each group. * P<0.05; ** P<0.01 and *** P<0.001 vs CTRL. B insert, representative immunoblots of GLUT2 and GLUT5 proteins from jejunum extracts of mice fed a SD and a high-calorie diet (HFD) showing increased amount GLUT2 and GLUT5 proteins when mice were fed a HFD in comparison to those fed a SD.
###end p 41
###begin p 42
###xml 104 110 104 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g004">fig. 4</xref>
###xml 290 296 290 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g004">fig. 4</xref>
###xml 528 534 528 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g004">fig. 4</xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
This acute effect of leptin was still observed after 7 days of daily treatment of the mice with leptin (fig. 4, B) and was exacerbated in mice fed on a HFD. In mice fed with HFD for 7 days in comparison to those fed with ND, the levels GLUT2 and GLUT5 proteins are significantly increased (fig. 4, B insert). Moreover, treatment of HFD mice with leptin by gavage, led to a dramatic increase in the mRNA levels with a 6-fold increase in GLUT2 mRNA (P<0.001) and a 9-fold increase in GLUT5 mRNA (P<0.001) in vehicle-treated mice (fig. 4, B).
###end p 42
###begin title 43
The Actions of Leptin Are Followed by Changes in Blood Fructose and Glucose Levels
###end title 43
###begin p 44
###xml 50 52 50 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 100 102 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 148 154 148 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g005">fig. 5</xref>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 434 436 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 568 574 568 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g005">fig. 5</xref>
As expected, oral administration of radiolabelled 14C-fructose induced a time-dependent increase of 14C fructose in blood in parallel with glucose (fig. 5, A). When fructose was given in combination with leptin, a rapid and significant increase in fructose-induced hyperglycaemia occurred as soon as 15 min. The +20% increase (P<0.05 vs. fructose) reached at 15 min was maintained over the 120 min period. At that time, the amount of 14C fructose detected in the liver was significantly 2-fold higher with fructose in combination with leptin than with fructose alone (fig. 5, B).
###end p 44
###begin title 45
Luminal leptin increases fructose-induced hyperglycaemia and hepatic content of fructose.
###end title 45
###begin p 46
###xml 34 35 34 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 73 74 73 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 487 489 487 489 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C,</bold>
###xml 725 746 725 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Materials and Methods</italic>
###xml 725 746 725 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4"><italic>Materials and Methods</italic></xref>
###xml 803 812 803 812 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C insert,</bold>
###xml 1076 1078 1074 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1097 1099 1095 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
Changes in plasma glucose levels (A) and in hepatic content of fructose (B). A solution of fructose (2 g/kg) containing radiolabelled [14C]-fructose was given by gavage without (control) or with 3 ng/g leptin to 16-hour fasted mice. Before starting the oral fructose tolerance test (OFTT), blood samples were taken from the tail and glucose levels was determined using Accu-Chek. At 120 minutes, the radioactivity in liver was counted and used to calculate the hepatic content fructose. C, changes in blood glucose levels as a function of plasma insulin levels. Fifteen minutes after oral administration of fructose (2 g/kg) without (control) or with 3 ng/g leptin to 16-hour fasted mice, blood was collected as described in Materials and Methods for determination of plasma glucose and insulin levels. C insert, are the measured area under curves at time 60 min after oral load of fructose (1 or 2 g/kg) without or with 3 ng/g leptin. Each column represents the mean+/-SEM of n = 8 mice for saline and leptin, n = 12 for each amount of fructose and fructose+leptin. * P<0.05 vs. saline; # P<0.05 vs fructose.
###end p 46
###begin p 47
###xml 456 462 456 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g005">fig. 5</xref>
###xml 719 725 719 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g005">fig. 5</xref>
This enhancement of fructose-induced glycaemia by leptin given orally was dependent on the amount of ingested fructose. Indeed, when the same dose of leptin (3 ng/g) was combined with low amount of fructose (1 g/kg), an increase in fructose-induced hyperglycaemia was also observed but, at levels significantly lower than those levels seen with 2 g/kg fructose (data not shown). The areas under curves for both low (1 g/kg) and the high (2 g/kg) fructose (fig. 5, C insert) were significantly increased when leptin was given in association with fructose. Plasma insulin levels, 15 min after administration of fructose alone or in combination with leptin, significantly increased in parallel with the levels of glucose (fig. 5, C). The increase in circulating levels of glucose and in liver fructose content after oral fructose either alone or in combination with leptin, suggests a possible enterocyte and/or liver production of glucose. To verify these possibilities, we quantified mRNA levels of some key enzymes involved in gluconeogenesis.
###end p 47
###begin title 48
Changes in mRNA of Key Gluconeogenesis Enzymes
###end title 48
###begin p 49
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Cui2">[27]</xref>
###xml 375 381 375 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g006">fig. 6</xref>
###xml 629 635 629 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g006">fig. 6</xref>
###xml 761 767 761 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g006">fig. 6</xref>
Previous studies have shown that, together with increased GLUT5 mRNA, the expression of genes encoding gluconeogenic enzymes also increased significantly after luminal fructose [27]. We found that oral load of fructose induced a significant increase in the levels of FK, F1,6BPase and G6Pase mRNAs and did not significantly affect PEPCK mRNA levels in jejunum and the liver (fig. 6). Leptin given by gavage did not significantly modify mRNA levels of these enzymes. When combined with oral fructose, leptin potentiated fructose-induced increase in the levels of FK, F1,6BPase and G6Pase mRNA both in the intestine and the liver (fig. 6). These changes in F1,6BPase and G6Pase mRNA levels paralleled those of their protein levels in the intestine and the liver (fig. 6 insert).
###end p 49
###begin title 50
Leptin given orally potentiates fructose-induced mRNA levels of enzymes involved in glucose metabolism in intestine and the liver.
###end title 50
###begin p 51
###xml 351 358 351 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inserts</bold>
###xml 509 512 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
Total RNA was extracted from jejunum mucosa and the liver, 4 hours after oral administration of saline (CTRL) or 3 ng/g leptin, oral fructose (2 g/kg) or both, in fasted mice. Q-RT PCR analysis was performed in duplicate using specific oligonucleotides for fructokinase, F1,6BPase, G6Pase and PEPCK genes, left columns: jejunum, right columns: liver. Inserts are representative immunoblots of F1,6BPase, glucose-6-phosphatase (G6Pase). Results are means+/-SEM for 6 mice in each group. * P<0.05 and ** P<0.01 vs. CTRL.
###end p 51
###begin title 52
Changes in mRNA levels of Some Enzymes of Lipid Metabolism
###end title 52
###begin p 53
###xml 124 131 124 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007935-t001">Table 1</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kersten1">[28]</xref>
###xml 613 619 613 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g007">fig. 7</xref>
In addition to the mild hyperglycaemia induced by fructose, the levels of blood triglycerides were significantly increased (Table 1). Thus, we first questioned whether oral load of fructose without or with leptin could modify the expression of Fasting-induced adipocyte factor (Fiaf). The Fiaf gene encodes a secreted lipoprotein lipase (LPL) inhibitor that is also produced in intestinal epithelium and the liver [28]. We found unexpectedly that oral load of fructose induced a significant 4-fold (P<0.01 vs. CTRL) and 3-fold (P<0.01 vs. CTRL) reduction in intestinal and hepatic Fiaf mRNA levels, respectively (fig. 7, A, B). When leptin alone was given orally, there were no significant changes in the levels of Fiaf mRNA both in intestine and the liver. However, when combined with fructose, leptin exacerbated fructose-induced decrease in Fiaf mRNA levels. This suppression of Fiaf mRNA levels is likely to result in an increase in LPL activity, an enzyme mediating the rate-limiting step for triglyceride-derived fatty acid production.
###end p 53
###begin title 54
Changes in Fiaf, hepatic SREBP-1c, ACC-1 and FAS mRNA in response to oral administration of fructose or leptin or both.
###end title 54
###begin p 55
###xml 278 282 278 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, B</bold>
###xml 326 327 326 327 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 346 347 346 347 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 366 367 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 499 501 497 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
Total RNA was extracted from jejunum mucosa and the liver, 4 hours after oral administration of saline (CTRL), leptin (3 ng/g), oral fructose (2 g/kg) or both, in fasted mice. QRT-PCR analysis was performed in duplicate using specific oligonucleotides targeting genes encoding (A, B) fasting-induced adipocyte factor (Fiaf), (C) liver SREBP-1c, (D) liver ACC-1 and (E) liver FAS. Results are means+/-SEM for 6 mice in each group are expressed as mRNA levels relative expression. * P<0.05; ** P<0.01 vs CTRL.
###end p 55
###begin title 56
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Plasma levels in 18-hour fasted mice receiving orally saline (CTRL), fructose (2 g/kg), leptin (3 ng/g) or fructose with leptin.
###end title 56
###begin p 57
###xml 83 85 83 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in</italic>
###xml 85 105 85 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Material and Methods</italic>
###xml 85 105 85 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4"><italic>Material and Methods</italic></xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed 4 hours after gavage, blood was collected, processed as described inMaterial and Methods and used to determine biochemical parameters.
###end p 57
###begin p 58
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Data are expressed as mean+/-SEM of n = 8 mice per group. One-way ANOVA followed by a multiple comparisons Tukey t-test were used for statistical analysis.
###end p 58
###begin p 59
P<0.05,
###end p 59
###begin p 60
###xml 7 10 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
P<0.01 vs. CTRL;
###end p 60
###begin p 61
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
#P<0.05 vs. fructose alone.
###end p 61
###begin p 62
###xml 270 277 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g007">fig. 7C</xref>
###xml 385 388 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 527 533 527 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g007">fig. 7</xref>
###xml 732 738 732 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g008">fig. 8</xref>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
Second, given that fructose consumption can promote lipogenesis in liver, the main site of fructose metabolism, the mRNA levels of SREBP-1c (a transcription factor targeting lipogenic genes) and two lipogenic enzymes were examined specifically in the liver. As shown in fig. 7C, levels of SREBP-1c mRNA were twice as high in mice receiving oral fructose alone than in controls (P<0.01 vs. CTRL). This effect was more potent when combined with leptin (P<0.05 vs. fructose alone). In parallel, hepatic ACC-1 and FAS mRNA levels (fig. 7, D, E) significantly increased and this increase was boosted when leptin was added (P<0.05 vs. fructose). The changes in the levels of ACC-1 and FAS mRNA paralleled those of ACC-1 and FAS proteins (fig. 8, A, C).
###end p 62
###begin title 63
Changes in hepatic ACC-1 and FAS proteins in response to fructose, leptin or both given orally.
###end title 63
###begin p 64
###xml 502 505 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
Proteins were extracted from jejunum mucosa and the liver, 4 hours after oral administration of saline, leptin (3 ng/g), oral fructose (2 g/kg) or both, in fasted mice. Representative immunoblots of phosphorylated ACC-1, total ACC-1, FAS and beta-actin protein in liver extracts. Lane 1: control; lane 2: Fructose 2 g/kg: lane 3: leptin 3 ng/g; lane 4: fructose in combination with leptin. Results of densitometric analysis are expressed as mean+/-SEM of 6 mice in each group. ** P<0.01 and *** P<0.01 vs. CTRL.
###end p 64
###begin p 65
###xml 145 152 145 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g008">fig. 8B</xref>
To further assess the impact of increased expression of ACC-1, phosphorylation of the enzyme was determined as an index of activity. As shown in fig. 8B, the phosphorylation of ACC-1 protein significantly decreased by 2-fold after oral load of fructose and by 3-fold when combined with leptin, indicating an increased ACC-1 activity. It is noteworthy that oral leptin alone significantly increased by 3-fold the phosphorylation of ACC-1 indicating that leptin given orally inactivates ACC-1 in the liver.
###end p 65
###begin title 66
Oral Fructose Rapidly Increases Luminal Content of Leptin in Gastric Juice without Affecting Plasma Leptin Levels
###end title 66
###begin p 67
###xml 183 189 183 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g009">fig. 9</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Bado1">[10]</xref>
###xml 739 745 739 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g009">fig. 9</xref>
###xml 844 851 844 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007935-t001">Table 1</xref>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10116">rats</span>
To determine the physiological relevance of these results, we analyzed the effects of oral fructose on luminal contents of leptin from stomach and the small intestine in fasted mice (fig. 9). Unexpectedly, oral load of fructose but not galactose, resulted in a dramatic 10-fold increase in basal leptin content in gastric juice (P<0.05 vs CTRL). This effect was rapid and seen as early as 15 min. This rapid increase was similar to that induced by i.p. administration of CCK-8 (used as a positive control) in agreement with our previous findings in rats [10]. It is noteworthy that during this 15-min period, the increase in gastric leptin output in response to fructose was not associated with significant change in plasma leptin levels (fig. 9). However, 4 hours after oral fructose, the levels of plasma leptin were significantly increased (Table 1) probably reflecting the contribution of fat tissues.
###end p 67
###begin title 68
Release of leptin in gastric juice in response to oral load of fructose or galactose.
###end title 68
###begin p 69
###xml 346 369 346 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in Materials &amp; Methods.</italic>
###xml 346 369 346 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4"><italic>in Materials &amp; Methods.</italic></xref>
###xml 410 411 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 465 466 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 479 480 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 486 488 484 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Changes in the amount of leptin released in the gastric juice and in plasma in mice fasted overnight and receiving an oral load of saline (CTRL), fructose [Fruct. 2 g/kg)], galactose (Gal. 6 g/kg) or intraperitoneal injection of 10 ng/g CCK-8. Leptin immunoreactivity was determined by RIA in 15-min collected juice from the stomach as described in Materials & Methods. Data are expressed as the mean+/-SEM of n = 6 in control group and n = 5 in each other group. *P<0.05 and ***P<0.01 vs CTRL.
###end p 69
###begin title 70
Discussion
###end title 70
###begin p 71
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 252 260 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The small intestine is the primary site of absorption of dietary sugars. Thus, a better understanding of the regulatory mechanisms involved in their entry and exit from intestinal epithelium to blood, is of great interest. In this combined in vivo and in vitro approaches, we showed that intestinal GLUT2 and GLUT5 transporters are direct targets of luminal leptin detected in the intestinal lumen and originating from the stomach. Indeed, introduction of exogenous leptin into intestinal lumen resulted in an up-regulation of transepithelial transport of fructose, a concurrent potentiation of circulating levels of glucose, and an increase in fructose content in the liver. These effects were accompanied by increased circulating levels of triglycerides, suppression of Fiaf expression both in intestinal epithelium and the liver, and by induction of hepatic SREBP-1c transcription factor, targeting genes in the fatty acid biosynthesis pathway. These findings may have physiological implications. Thus, we demonstrated for the first time that oral load of fructose, but not galactose rapidly induces release of gastric leptin which enters the intestine at a concentration compatible with the activation of leptin receptors. Collectively, these data sustain that in the small intestine, a positive regulatory control loop exists between gut leptin and two transporters: the specific GLUT5 fructose transporter and the apical GLUT2 which is active in conditions of high concentrations of glucose/galactose and which has a minor participation in fructose transport. This regulatory loop appears to be connected to metabolic functions in the liver.
###end p 71
###begin p 72
###xml 521 524 515 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kellett2">[2]</xref>
###xml 526 529 520 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ducroc1">[9]</xref>
###xml 531 535 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Helliwell1">[23]</xref>
###xml 748 752 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Bado1">[10]</xref>
###xml 787 791 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Guilmeau1">[12]</xref>
###xml 793 797 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Guilmeau2">[30]</xref>
###xml 1079 1088 1069 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">review in</italic>
###xml 1088 1092 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Hardie1">[24]</xref>
###xml 1288 1291 1274 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e</italic>
###xml 1322 1326 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Viollet1">[29]</xref>
###xml 1328 1332 1314 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Jorgensen1">[31]</xref>
###xml 1333 1337 1319 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Janovska1">[33]</xref>
###xml 1559 1563 1541 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Walker1">[34]</xref>
###xml 1680 1681 1658 1659 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1690 1694 1668 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Viollet1">[29]</xref>
###xml 1749 1750 1723 1724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1985 1988 1959 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isc</italic>
###xml 2015 2022 1989 1996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007935.s002">fig. S1</xref>
###xml 2203 2204 2173 2174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2287 2288 2253 2254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2325 2329 2291 2295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Walker1">[34]</xref>
###xml 2582 2585 2548 2551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ducroc1">[9]</xref>
###xml 2639 2640 2601 2602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2755 2756 2713 2714 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2998 3002 2956 2960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Walker1">[34]</xref>
###xml 1685 1689 <span type="species:ncbi:10090">mice</span>
###xml 2208 2212 <span type="species:ncbi:10090">mice</span>
###xml 2474 2478 <span type="species:ncbi:10090">mice</span>
###xml 2882 2888 <span type="species:ncbi:10090">murine</span>
Firstly, we showed that mucosal leptin increases GLUT2 and GLUT5 transporter activity as well as insertion of GLUT2 and GLUT5 in the brush-border membrane (BBM). These changes were leptin-receptor specific since they were blocked by leptin antagonist and correlated with the phosphorylation/activation of PKCbetaII at the BBM. This activation of PKCbetaII enhanced the insertion of GLUT2/5 and reduced the insertion of the energy-dependent SGLT1 transporters into the brush-border membrane, consistent with previous data [2], [9], [23]. The findings have clear physiological implications: immediately after a meal, a high local concentration of sugars is generated at the surface of the brush-border by disaccharidases. The released gastric leptin [10] enters the lumen of the intestine [12], [30], where it may then up-regulate GLUT2/GLUT5 transporter activity to match dietary intake. The intracellular mechanisms of such a rapid regulation of absorption by luminal leptin involve the activation of AMPKalpha which is known to play a central role in regulating glucose uptake (review in[24]). In this context, we showed that luminally acting leptin phosphorylates/activates AMPKalpha in the intestine consistent with previous data reporting similar findings in other biological systems i.e. liver, hypothalamus, muscles [29], [31]-[33]. Interestingly, we found that leptin given orally can boost the fructose activation of AMPKalpha leading to increased GLUT2/GLUT5 transport activities, indicating that these transporters are responsive to AMPK activation [34]. We further elucidated a role of AMPK in the leptin regulation of intestinal hexoses transporters by using AMPKalpha2 KO mice [29]. We found that deletion of the catalytic subunit alpha2, which does not alter the architecture of the jejunum, potently lowered levels of GLUT2 and GLUT5 and elevated levels of SGLT1. This increase in SGLT1 levels correlated with an increase in its activity, as measured by glucose-induced Isc using the Ussing chamber (fig. S1), and might represent a compensatory effect in the process of sugar absorption. Alternatively, the reduced expression of GLUT2/GLUT5 and the increased SGLT1 expression in AMPKalpha2 KO mice could reflect a differential regulation of these transporters by AMPKalpha2 as reported by Walker and coworkers [34] showing that activation of AMPK results in an up-regulation of GLUT2 and a concurrent down-regulation of SGLT-1. Moreover, in the jejunum of WT mice, luminal leptin inhibited SGLT1-mediated glucose transport which is in line with our previous findings [9]. However, we did not observe this effect in AMPKalpha2 KO jejunum, suggesting that leptin acting from the lumen of the intestinal epithelium requires the catalytic alpha2 subunit of AMPK for this inhibitory effect. Our data can be compared to previous findings showing that activation of AMPK in murine jejunum tissues, increases glucose uptake which can be attributed to an increased amount of GLUT2 in the BBM [34].
###end p 72
###begin p 73
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 102 105 102 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ferraris1">[4]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Cui2">[27]</xref>
###xml 280 287 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-White1">[35]</xref>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Tartaglia1">[36]</xref>
###xml 992 999 992 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007935.s004">fig. S3</xref>
On the other hand, in vivo luminal fructose increases GLUT2 and GLUT5 mRNA levels as reported earlier [4], [27] and this effect is potentiated by leptin given orally. This suggests that luminal leptin can replenish the pool of the transporters by inducing gene transcription. The in vivo dose of leptin was comparable to the doses detected in gastric juice (0.9 to 1.2 nmol/L) in response to fructose as well as the levels of leptin detected in intestinal juice (0.7 nmol/L). These concentrations of leptin can activate leptin receptor [35], [36]. Our demonstration that the actions of leptin require active jejunal leptin receptors, led us to propose a two-step mode of action for luminal leptin regulation of sugars transport, involving a rapid recruitment of GLUT2/GLUT5 to the BBM to deal with the inflow of dietary sugars during a meal, followed by transcription of the corresponding genes, allowing the reconstitution of the cytosolic pool of transporters. These data are summarized in fig. S3.
###end p 73
###begin p 74
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Shapiro1">[37]</xref>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Teff1">[38]</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Notably, the fructose-induced increase in GLUT5 mRNA levels markedly increased when mice fed with a HFD received chronically leptin given orally. This suggests that gut leptin might be a key molecule for the enterocyte in adapting the levels of carbohydrate transporters to the diet. This is in line with recent observations showing that, on an already potent obesity-inducing hypercaloric diet, fructose induces leptin-resistance leading to pronounced susceptibility to increased weight gain [37], [38].
###end p 74
###begin p 75
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
This leptin up-regulation of GLUT2/GLUT5 affects in vivo circulating levels of glucose and triglycerides. Indeed, oral leptin enhanced fructose-induced mild hyperglycaemia and the size of this effect is dependent on the amount of fructose absorbed. As a consequence of increased hyperglycaemia, plasma insulin levels increased to adapt glucose uptake by the different tissues. Moreover, all the changes occurring after oral leptin are not associated with changes in plasma leptin levels, indicating that the primary site of action of oral leptin is within the gut mucosa.
###end p 75
###begin p 76
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Chong1">[39]</xref>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Rajas1">[40]</xref>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Crosson1">[41]</xref>
###xml 1438 1442 1438 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Rajas2">[42]</xref>
###xml 272 278 <span type="species:ncbi:9606">humans</span>
In addition to observing the increase in plasma glucose levels after an oral load of fructose, the majority of the absorbed fructose appears in the blood and liver, the main site of fructose metabolism. These findings were consistent with data from studies in rodents and humans [39]. Thus, the increased plasma glucose could originate from fructose metabolism in the liver and possibly from enterocytes. Fructose is metabolised mainly in the liver through two alternative pathways: the fructose 1-phosphate pathway, involving fructokinase, and/or the fructose 6-phosphate pathways. In the enterocyte, fructose is metabolised by fructokinase through the fructose 1-phosphate pathway. As for the liver and kidney, the small intestine expresses gluconeogenesis genes such as those encoding G6Pase and PEPCK [40]. The transcription of these gluconeogenic genes is tightly controlled in the liver by substrates and various hormones [41]. Here, we demonstrate a potentiation by oral leptin of fructose-induced mRNA levels of FK-, F1,6BPase- and G6Pase-encoding genes in the liver and the jejunum. The observed increase in these enzymes mRNA is causally linked to the amount of fructose absorbed; indeed oral leptin alone fails to affect the levels of these enzymes. Thus, as in the liver, glucose produced by the enterocyte may contribute partly to fructose-induced hyperglycemia consistent with a neoglucogenic status for the small intestine [42].
###end p 76
###begin p 77
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Kersten1">[28]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Eckel1">[43]</xref>
###xml 842 849 842 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 961 965 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Backhed1">[44]</xref>
###xml 1098 1102 1098 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Foretz1">[45]</xref>
###xml 1104 1108 1104 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Foretz2">[46]</xref>
###xml 1493 1500 1493 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1587 1591 1587 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Obici1">[47]</xref>
###xml 1593 1597 1593 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Wakil1">[48]</xref>
###xml 2005 2009 2005 2009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Gao1">[49]</xref>
###xml 2911 2918 2911 2918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 2995 2999 2995 2999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Stanhope1">[50]</xref>
The leptin stimulation of GLUT5 fructose transport is associated with the unexpected reduction of the levels of Fiaf mRNA in both the intestine and the liver. Fiaf is a gene which encodes a physiologically relevant circulating inhibitor of LPL [28], an enzyme that promotes storage of triglycerides [43]. This reduction of intestinal and hepatic levels of Fiaf mRNA, is critically dependent upon the amount of absorbed fructose. Indeed, leptin alone given orally enhances Fiaf mRNA levels, implying that fructose is the primary signal controlling the levels of Fiaf mRNA. The suppression of Fiaf may increase LPL activity and thus activates storage of triglycerides in tissues such as the liver. Our data are reminiscent of those recently demonstrating an enterocyte-specific suppression of Fiaf by the gut microbiota leading to induction of de novo hepatic lipogenesis, probably through the increased conversion of dietary polysaccharides into monosaccharides [44]. The fact that leptin potentiates the fructose induction of SREBP-1c, a transcription factor targeting lipogenic genes in the liver [45], [46], strengthens this hypothesis. Interestingly, this leptin potentiation of fructose-induced SREBP-1c was associated with increased expression and activation of ACC-1, the key regulatory enzyme of fatty acid biosynthesis. The activation ACC-1 is expected to elevate the levels of malonyl-CoA in the liver. The concurrent increased expression of hepatic FAS which plays a central role in de novo lipogenesis, catalyzing reactions steps in the conversion of malonyl-CoA to palmitate [47], [48], may also indicate increased levels of palmitate. The surprising capacity of leptin given orally to phosphorylate/inactivate ACC-1 in the liver argues for a beneficial effect on the liver. This effect of gut leptin is quite different from the results showing that intracerebroventricular injection of leptin activates hypothalamic ACC, up-regulates the levels of malonyl-CoA and concomitantly inhibits AMPK [49]. We have no clear explanation for these discrepancies but undoubtedly they need to be clarified. The effects of leptin given orally on hepatic metabolic functions could be of great importance in terms of pharmacological manipulation of the expression of these key enzymes, but the mechanisms involved need to be elucidated. Actually, we cannot exclude that leptin given by oral route, could enter the liver in sufficient quantity to affect the hepatic expression of genes encoding key metabolic enzymes. Indeed, we demonstrated that oral fructose but not galactose, triggers a rapid and dramatic secretion of gastric leptin in gastric juice which is found at levels compatible with activation of leptin receptors in the intestinal lumen. These findings are of great interest in light with the recent data demonstrating that consuming fructose-sweetened, and not glucose sweetened, beverages increases de novo lipogenesis and increases visceral adiposity in overweight and obese adults [50].
###end p 77
###begin p 78
###xml 348 355 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007935-g010">fig. 10</xref>
###xml 613 619 <span type="species:ncbi:9606">humans</span>
Our data sustain the existence of a positive regulatory control loop between gut leptin and fructose, in which fructose triggers the release of gastric leptin which in turn up-regulates GLUT2/GLUT5 leading to increase fructose absorption and changes in some metabolic functions in the liver. We have summarized these intestine-liver cross talks in fig. 10. This regulatory control loop appears to be a new mechanism (possibly pathogenic) by which fructose consumption rapidly becomes highly lipogenic and deleterious by increasing adiposity. Although rodents may not have identical metabolic pathways to those of humans, our findings provide basis for introducing further nutritional recommendations relative to excess consumption of fructose.
###end p 78
###begin title 79
Schematic view of the regulatory control loop between gut leptin and fructose transporters.
###end title 79
###begin p 80
Ingestion of fructose increased the release of gastric leptin which enters together with fructose the intestine. The concentrations of leptin detected in intestinal juice are suitable with activation of leptin receptors. This luminal leptin operates through leptin receptor (Ob-R) to increase the clearance of fructose from the intestinal lumen predominantly via the brush border GLUT5 transporter. Fructose and glucose exit the enterocyte through the basolateral GLUT2 transporter into the blood and are delivered to various organs including the liver. Fructose enters into the liver, induces SREBP-1c a transcription factor targeting genes in the lipogenic program. This cluster of events which are amplified by gut leptin is likely to provide the mechanism for rapidly acquired adiposity. FK: fructokinase, G6Pase: glucose-6-phosphatase, Fiaf: Fasting-induced adipocyte factor, TG triglycerides, SBREP-1c: Sterol Regulatory Element Binding Protein-1c; ACC-1 Acetyl-coA Carboxylase isoform 1, FAS, fatty acid synthase.
###end p 80
###begin title 81
Materials and Methods
###end title 81
###begin title 82
Animals
###end title 82
###begin p 83
###xml 142 143 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 186 187 178 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 187 190 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 177 190 173 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMPK&#945;<sub>2</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 213 217 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Viollet1">[29]</xref>
###xml 43 54 <span type="species:ncbi:10116">Wistar rats</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
Animals used for our experiments were male Wistar rats, C57BL/6J mice 6-8 weeks old (Elevage Janvier, Le genest-St-Isle, France) and AMPKalpha2 catalytic subunit gene knockout (AMPKalpha2-/-) 10-12 weeks-old mice [29]. All procedures were performed in accordance with the principles and guidelines established by the European Convention for the Protection of Laboratory concerning care and the use of laboratory and with the authorization order Ndegrees B75-18-02 delivered by Ministry of Agriculture and Prefecture of Paris, France.
###end p 83
###begin title 84
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
###xml 43 46 <span type="species:ncbi:10116">Rat</span>
Transport of Galactose and Fructose in the Rat Jejunal Loop In Vitro
###end title 84
###begin p 85
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 244 246 240 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 263 265 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 554 556 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 362 368 <span type="species:ncbi:10090">murine</span>
The animals were killed, and the transport was monitored using the in vitro jejunal loop model. Briefly, a 5-cm segment of jejunum was filled with a Krebs buffer pH 6 containing 100 mM D-galactose or 30 mM fructose added with 0.1 microCi/mL [D-14C]-galactose or [14C]-fructose (specific activity 57 and 267 mCi/mmoL, respectively) in absence and the presence of murine leptin (PeproTech Neuilly/Seine France). CCK-8 (Sigma Chemicals, St Louis Mo) was added in the bath solution (serosal side) as a positive control. The effect of leptin on transport of [14C]-mannitol as non-transported substrate was also determined.
###end p 85
###begin p 86
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Salomon1">[20]</xref>
###xml 324 327 324 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">app</sub>
###xml 414 417 414 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">app</sub>
###xml 432 433 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 513 514 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
In experiments in which phloretin, cytochalasin B or L39A/D40A/F41A mutein (1, 10 nM) an antagonist of leptin-receptor [20] were used, the jejunum segments were preincubated for 5 min before addition of galactose or fructose solution. The incubation medium was sampled and radioactivity was counted. Apparent permeability (Papp) was used to assess mucosal to serosal transport according to the following equation Papp = (dQ/dt).(V/Q0.A) where V is the volume of the incubation medium, A is the area of the loop, Q0 is the total radiolabelled galactose or fructose introduced into the loop and dQ/dt is the flux across the jejunum loop.
###end p 86
###begin title 87
Western Blot Analysis of GLUT2 and GLUT5 in Membrane Preparations
###end title 87
###begin p 88
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 126 133 126 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 603 606 603 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Ducroc1">[9]</xref>
###xml 15 19 <span type="species:ncbi:10116">rats</span>
###xml 1034 1040 <span type="species:ncbi:9986">rabbit</span>
16-hour fasted rats were anesthetized by pentobarbital and laparotomized for in situ experiments. Jejunal loops were isolated in situ and filled with a Krebs buffer without or with leptin. After 3 min of incubation, these loops were injected with 100 mM unlabelled galactose or 30 mM fructose. After a further 5 min incubation, the loops were removed, opened along the mesenteric border and the mucosa was scrapped off on ice. Total proteins and brush border membranes (BBM) were prepared in PBS containing protease and phosphatase inhibitors (Sigma Chemicals, St Louis Mo, USA) as previously described [9] and enrichment was estimated by determination of alkaline phosphatase activity (20-fold increase of activity in BBM). Protein concentration was quantified using the BCA protein assay Kit (Pierce, Rockford Il, USA) and used for western blot analysis. Solubilised proteins (50-100 microg) were resolved on SDS-PAGE in gels containing 8-10% acrylamide, transferred to nitrocellulose membranes and subjected to immunoblotting with rabbit polyclonal antibodies anti-GLUT2 (sc-9117) and anti-GLUT5 (sc-9117) [Santa Cruz Biotechnology, Inc., CA, USA). Immune complexes were detected by enhanced chemiluminescence (ECL; Perkin Elmer Boston, MA, USA). The intensity of the specific immunoreactive bands was quantified with Scion image (NIH, Scion Corporation, Bethesda, MD, USA). The results were expressed in relation to control, and the mean value of controls was arbitrarily set to 1 and used for calculations.
###end p 88
###begin title 89
###xml 48 49 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 49 52 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 53 57 <span type="species:ncbi:10090">Mice</span>
Glucose Transporters in the Jejunum of AMPKalpha2-/- Mice
###end title 89
###begin p 90
###xml 9 10 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 10 13 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 498 507 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007935.s003">Figure S2</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
AMPKalpha2-/- mice were killed by cervical dislocation and the jejunum was removed for histological analysis by routine techniques. Sections (4 microm) were mounted on glass slides, stained with hematoxylin-eosin (H&E) and examined by light microscopy. Concerning Western blot analysis, proteins were extracted from jejunal mucosa scrapings as described above. For functional studies, a third jejunum fragment was used for SGLT-1 mediated glucose transport using the Ussing chamber as described in Figure S2.
###end p 90
###begin title 91
Acute Effects of Leptin on Jejunal GLUT2 and GLUT5 mRNA Levels
###end title 91
###begin p 92
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
###xml 260 264 <span type="species:ncbi:10090">Mice</span>
###xml 677 683 <span type="species:ncbi:9986">rabbit</span>
###xml 763 769 <span type="species:ncbi:9986">rabbit</span>
###xml 810 814 <span type="species:ncbi:9925">goat</span>
###xml 934 940 <span type="species:ncbi:9986">rabbit</span>
###xml 985 991 <span type="species:ncbi:9986">rabbit</span>
18-hour fasted mice were treated with vehicle or 3 ng/g murine leptin administered by gavage. Four hours later, blood was collected from the retro-orbital sinus with heparinized capillary Pasteur pipettes, centrifuged and the plasma was stored at -20degreesC. Mice were sacrificed, a fragment of their liver was removed and immediately frozen in liquid nitrogen. The jejunum was removed, rinsed and the mucosa was scrapped off and immediately frozen. All the collected tissues were stored at -80degreesC until use for extraction of total RNA for qRT-PCR analysis and for extraction of total protein for western blot analysis as described above, using the following antibodies: rabbit anti-fructose-1,6-bisphosphatase (anti-FBPase) polyclonal antibody (sc-66946), rabbit anti-FAS polyclonal antibody (sc-1023), goat anti-glucose-6-phosphatase (anti-G6Pase) polyclonal antibody (sc-33839) purchased from Santa Cruz (Santa Cruz, CA) and rabbit purified anti-ACC-1 monoclonal antibody and rabbit purified anti-phospho ACC-1 (Ser79) polyclonal antibody were purchased from Millipore (Millipore SAS, Molsheim, France).
###end p 92
###begin title 93
###xml 60 64 <span type="species:ncbi:10090">Mice</span>
Chronic Effects of Leptin on GLUT2 and GLUT5 mRNA Levels in Mice Fed a High Fat Diet (HFD)
###end title 93
###begin p 94
###xml 120 130 120 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Begriche1">[51]</xref>
###xml 364 368 <span type="species:ncbi:10090">Mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
Experiments were performed on 6-week-old male C57BL/6J purchased from Janvier (Le-Genest-St-Isle, France) that were fed ad libitum a standard diet (SD: A04 biscuits; UAR, Villemoisson-sur-Orge, France) or a high-fat high-sucrose diet (HFD) purchased from SAFE, Augy, France. The HFD diet includes 36% fat, 35% carbohydrates mainly saccharose and 18% protein [51]. Mice fed on a SD or a HFD were treated every day with 3 ng/g leptin for 7 days by gavage. At day 8, blood was collected from non-fasted mice, the jejunum mucosa was scrapped off as described above and used for qRT-PCR and western blot analysis of transporters.
###end p 94
###begin title 95
RNA Preparation and Real-Time PCR Analysis (qRT-PCR)
###end title 95
###begin p 96
###xml 284 291 284 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007935-t002">Table 2</xref>
###xml 263 268 <span type="species:ncbi:10090">mouse</span>
Total RNA was extracted from the jejunal mucosa samples or liver fragments with the Trizol reagent (Qiagen). Quantitative RT-PCR was carried out on Light Cycler System 480 (Roche Diagnostics) as previously described. The oligonucleotides primers sequences of the mouse genes studied (Table 2) were designed with Oligo 4 software and synthesized by Eurogentec (France).
###end p 96
###begin title 97
Sequences of primers used for real time quantitative PCR.
###end title 97
###begin title 98
Oral Fructose Tolerance Test
###end title 98
###begin p 99
###xml 308 310 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
Three sets of experiments were conducted with the 16-hour fasted mice. In the first set of experiments, we determined whether leptin could increase fructose absorption in conscious animals. To this end, mice were given an oral load of 2 g fructose per kg of body weight added with 0.1 microCi radiolabelled [14C]-fructose without (control) or with 3 ng/g leptin. Before starting the oral fructose tolerance test (OFTT), blood samples were taken from the tail and blood glucose levels were determined (ACCU-CHEK; Roche Diagnostics, Meylan, France). The bleeds were further taken at 15, 30, 60, 90 and 120 min after administration. At 120 minutes, blood was collected, mice were sacrificed and segments of jejunum and the liver were removed. The radioactivity was counted and used to calculate the amount of fructose in these compartments. For jejunum and the liver, the data were expressed as moles of fructose per gram wet tissue.
###end p 99
###begin p 100
###xml 124 128 <span type="species:ncbi:10090">Mice</span>
The second set of experiments was designed to determine if the effects of leptin depend on the amount of ingested fructose. Mice were given an oral load of 1 g or 2 g unlabelled D-fructose per kg of body weight without (control) or with 3 ng/g leptin. Blood samples were taken and blood glucose levels were determined as mentioned above. These experiments were performed with 16 individual animals, each animal being its own control. The animals were allowed to recovery during 72 hours between two experiments.
###end p 100
###begin p 101
###xml 37 41 <span type="species:ncbi:10090">mice</span>
The third set of experiments, fasted mice were divided into four groups and treated without or with fructose in the presence or the absence of 3 ng/g leptin. Fifteen minutes later, blood was drawn from the retro-orbital sinus with heparinised capillary Pasteur pipettes, centrifuged and the plasma was stored at -20degreesC until determination of insulin levels by RIA.
###end p 101
###begin title 102
Effects of Fructose on Luminal Leptin Contents from Stomach and the Intestine
###end title 102
###begin p 103
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">Mice</span>
18-hour fasted mice were treated by gavage with saline, fructose (1 g and 2 g/kg body weight), 6 g/kg galactose or with intraperitoneal injection of 10 ng/g CCK-8 as positive control. Fifteen minutes later, blood was drawn from the retro-orbital sinus, centrifuged and the plasma stored at -20degreesC until RIA of leptin. Mice were sacrificed, their stomachs and their small intestines (from duodenum to ileum) were removed and then flushed each with 1 ml of PBS buffer containing 500 UI/ml aprotinin; the luminal contents were collected on ice, centrifuged at 3,000 rpm for 10 min and the supernatants were used for a leptin determination by a RIA.
###end p 103
###begin title 104
Statistical Analysis
###end title 104
###begin p 105
All values are expressed as means+/-SEM. One- or Two-way ANOVA followed by Tukey-Kramer multiple comparisons post-test was used to compare the groups. Statistical analysis was performed with Graph Pad Prism version 3.0 for Windows (Graph Pad Software, San Diego, CA, USA). Values of P<0.05 were considered statistically significant for all analyses.
###end p 105
###begin title 106
Supporting Information
###end title 106
###begin p 107
###xml 130 131 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 116 119 <span type="species:ncbi:10116">rat</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
Luminal leptin increases GLUT2-mediated galactose transport and increases galactose levels in blood, in vivo in the rat. AMPKalpha2 KO mice had an increased expression and activity of SGLT1 in the jejunum.
###end p 107
###begin p 108
(0.04 MB DOC)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
###xml 374 378 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007935-Buyse1">[14]</xref>
###xml 316 320 <span type="species:ncbi:10116">rats</span>
Appearance of radiolabelled [14C]-galactose in blood after introduction into the jejunum. A solution of 100 mM galactose added with 0.1 microCi [14C]-galactose solution with saline or with 5 nM leptin alone or in association with 10 nM L39A/D40A/F41A leptin mutein (L39), was injected into jejunal loops from fasted rats fitted with carotid catheter as previously described [14]. Plasma galactose was significantly higher after treatment with luminal leptin than after treatment with vehicle. Results show incremental area under the curves (insert).*P<0.05 vs. saline, # vs. leptin.
###end p 110
###begin p 111
(3.39 MB TIF)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin p 113
###xml 93 94 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 330 331 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
Left panel: Western blot analysis of SGLT1 proteins in jejunum mucosa extracts from AMPKalpha2-/- and WT mice. Densitometric analysis of the blots was performed using NIH Image software and data are expressed as described above. Right panel: Effect of luminal leptin on SGLT1 transport activity in jejunum fragments from AMPKalpha2-/- and WT mice mounted in Ussing chamber. Vehicle or leptin was added in the mucosal bath 2 minutes before challenge with 10 mM glucose. Electrogenic chloride secretion in response to carbachol (100 microM) was used as a control. Values for Isc are expressed as mean+/-SEM of net increase in Isc (DeltaIsc) in microA/cm2; n = 5 mice in each group. *P<0.05 and **P<0.01 vs. control.
###end p 113
###begin p 114
(3.77 MB TIF)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin p 116
Summary of the mechanisms involved in the luminal leptin regulation of GLUT5 and GLUT2 transporters. Luminal leptin operating through leptin receptors phosphorylates/activates ERK, AMPKalpha, and PKCbetaII leading to recruitment of more GLUT2/GLUT5 into the BBM and the subsequent increase in galactose and fructose transport across the jejunum into the blood. Thereafter, leptin replenishes the cytoplasmic pool of these transporters by increasing GLUT2 and GLUT5 mRNA levels.
###end p 116
###begin p 117
(6.90 MB TIF)
###end p 117
###begin p 118
Click here for additional data file.
###end p 118
###begin p 119
The authors are grateful to Professor Arieh Gertler for the generous gift of leptin antagonists, to Sandra Guilmeau for the critical reading of the manuscript, to Bernard Fromenty and Karima Begriche for help with qRT-PCR analysis in liver and fruitful discussions. We thank Jean-Claude Marie for suggestions and linguistic revision of the manuscript.
###end p 119
###begin p 120
Part of this work was presented as an oral communication at the Digestive Week May-June 2009 at Chicago, Illinois and published as an abstract in Gastroenterology 2009; 136(5): 92A.
###end p 120
###begin title 121
References
###end title 121
###begin article-title 122
Apical GLUT2: a major pathway of intestinal sugar absorption.
###end article-title 122
###begin article-title 123
The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane.
###end article-title 123
###begin article-title 124
Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension.
###end article-title 124
###begin article-title 125
Dietary and developmental regulation of intestinal sugar transport.
###end article-title 125
###begin article-title 126
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Mechanism of beta-adrenergic agonist-induced transmural transport of glucose in rat small intestine. Regulation of phosphorylation of SGLT1 controls the function.
###end article-title 126
###begin article-title 127
###xml 34 37 <span type="species:ncbi:10116">rat</span>
Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2.
###end article-title 127
###begin article-title 128
###xml 45 48 <span type="species:ncbi:10116">rat</span>
Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo.
###end article-title 128
###begin article-title 129
Cholecystokinin decreases intestinal hexose absorption by a parallel reduction in SGLT1 abundance in the brush-border membrane.
###end article-title 129
###begin article-title 130
Luminal leptin induces rapid inhibition of active intestinal absorption of glucose mediated by sodium-glucose cotransporter 1.
###end article-title 130
###begin article-title 131
The stomach is a source of leptin.
###end article-title 131
###begin article-title 132
Secretion of soluble leptin receptors by exocrine and endocrine cells of the gastric mucosa.
###end article-title 132
###begin article-title 133
Duodenal leptin stimulates cholecystokinin secretion: evidence of a positive leptin-cholecystokinin feedback loop.
###end article-title 133
###begin article-title 134
Luminal leptin activates mucin-secreting goblet cells in the large bowel.
###end article-title 134
###begin article-title 135
PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.
###end article-title 135
###begin article-title 136
Endocrine and exocrine secretion of leptin by the gastric mucosa.
###end article-title 136
###begin article-title 137
###xml 71 76 <span type="species:ncbi:9606">human</span>
Luminal leptin enhances CD147/MCT-1-mediated uptake of butyrate in the human intestinal cell line Caco2-BBE.
###end article-title 137
###begin article-title 138
Fructose, weight gain, and the insulin resistance syndrome.
###end article-title 138
###begin article-title 139
###xml 29 33 <span type="species:ncbi:381124">corn</span>
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity.
###end article-title 139
###begin article-title 140
Sugar absorption in the intestine: the role of GLUT2.
###end article-title 140
###begin article-title 141
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 57 60 <span type="species:ncbi:10116">rat</span>
Large-scale preparation of biologically active mouse and rat leptins and their L39A/D40A/F41A muteins which act as potent antagonists.
###end article-title 141
###begin article-title 142
Development of leptin antagonists and their potential use in experimental biology and medicine.
###end article-title 142
###begin article-title 143
Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake.
###end article-title 143
###begin article-title 144
Intestinal sugar absorption is regulated by phosphorylation and turnover of protein kinase C betaII mediated by phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent pathways.
###end article-title 144
###begin article-title 145
AMPK: a key regulator of energy balance in the single cell and the whole organism.
###end article-title 145
###begin article-title 146
###xml 39 42 <span type="species:ncbi:10116">rat</span>
Fructose-induced increases in neonatal rat intestinal fructose transport involve the PI3-kinase/Akt signaling pathway.
###end article-title 146
###begin article-title 147
Fructose modulates GLUT5 mRNA stability in differentiated Caco-2 cells: role of cAMP-signalling pathway and PABP (polyadenylated-binding protein)-interacting protein (Paip) 2.
###end article-title 147
###begin article-title 148
###xml 61 65 <span type="species:ncbi:10116">rats</span>
Fructose-responsive genes in the small intestine of neonatal rats.
###end article-title 148
###begin article-title 149
Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.
###end article-title 149
###begin article-title 150
The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.
###end article-title 150
###begin article-title 151
Gastric leptin: a new manager of gastrointestinal function.
###end article-title 151
###begin article-title 152
Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle.
###end article-title 152
###begin article-title 153
AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
###end article-title 153
###begin article-title 154
AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
###end article-title 154
###begin article-title 155
5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK.
###end article-title 155
###begin article-title 156
Evidence for ligand-independent homo-oligomerization of leptin receptor (OB-R) isoforms: a proposed mechanism permitting productive long-form signaling in the presence of excess short-form expression.
###end article-title 156
###begin article-title 157
Identification and expression cloning of a leptin receptor, OB-R.
###end article-title 157
###begin article-title 158
Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding.
###end article-title 158
###begin article-title 159
###xml 136 141 <span type="species:ncbi:9606">women</span>
Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.
###end article-title 159
###begin article-title 160
Mechanisms for the acute effect of fructose on postprandial lipemia.
###end article-title 160
###begin article-title 161
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 126 130 <span type="species:ncbi:10116">rats</span>
The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats.
###end article-title 161
###begin article-title 162
Hormonal regulation of the phosphoenolpyruvate carboxykinase gene. Role of specific CCAAT/enhancer-binding protein isoforms.
###end article-title 162
###begin article-title 163
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Induction of PEPCK gene expression in insulinopenia in rat small intestine.
###end article-title 163
###begin article-title 164
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.
###end article-title 164
###begin article-title 165
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.
###end article-title 165
###begin article-title 166
Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes.
###end article-title 166
###begin article-title 167
ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose.
###end article-title 167
###begin article-title 168
Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production.
###end article-title 168
###begin article-title 169
Fatty acid metabolism: target for metabolic syndrome.
###end article-title 169
###begin article-title 170
Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake.
###end article-title 170
###begin article-title 171
###xml 157 163 <span type="species:ncbi:9606">humans</span>
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.
###end article-title 171
###begin article-title 172
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
###end article-title 172
###begin p 173
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 173
###begin p 174
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the INSERM (Institut National de la Sante et de la Recherche Medicale), the UFR of Medicine of University Paris 7 Denis Diderot, and by a grant (to YS ) of Societe Francophone de Nutrition Clinique et Metabolisme (SFNEP-Antadir Federation), a grant (to RD) of Association pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM-Becton Dickinson), and a grant (to AB) of Institut Benjamin Delessert. The funders have no role in study design, data collection, analysis, decision to publish or to prepare the manuscript.
###end p 174

